Ultrapotent SARS-CoV-2 neutralizing antibodies with protective efficacy against newly emerged mutational variants
Tingting Li(Tianjin University), Aishun Jin(Chongqing Medical University), Hongqing Zhang(Liaoning Technical University), Fengjiang Liu(Guangzhou Experimental Station), Haitao Yang(Fujian Medical University), Qian Chen(The Affiliated Yongchuan Hospital of Chongqing Medical University), Jingjing Huang(Chongqing Medical University), Guiji Zhang(Chongqing Medical University), Ailong Huang(Chongqing Medical University), Wei Xu(Beijing Geriatric Hospital), Yingyi Long(Chongqing Medical University), Song Mu, Shunhua Long(Chongqing Medical University), Kai Wang(Xinjiang Medical University), Xiaojian Han(Chongqing Medical University), Shuyi Song(Chongqing Medical University), Feiyang Luo(Zhujiang Hospital), Xiaoyun Ji(Southwest Jiaotong University), Zherui Zhang(Jilin University), Meiying Shen, Ni Tang(Ho Chi Minh City University of Education), Zhenghong Yuan(Shanghai Medical College of Fudan University), Hangtian Guo(Nanjing University), Bo Zhang(Chinese Academy of Sciences), Na Li(Shenzhen Institutes of Advanced Technology), Wei Wang(Sichuan University), Yanan Zhang(Chinese Academy of Sciences), Jianwei Wang(Zhejiang Cancer Hospital), Jie Hu(People's Hospital of Kaizhou District), Li Luo(Chongqing Medical University), Youhua Xie(Shanghai Medical College of Fudan University), Huajun Zhang(Chinese Academy of Sciences), Yingming Wang(China Pharmaceutical University), Wang Wang(Nanchang University), Chenjian Gu(Washington University in St. Louis), Xia Cai(Fudan University), Yanan Hao(North China University of Science and Technology), Changlong He(Army Medical University), Yang Wu(Shanghai Medical College of Fudan University), Fengxia Gao(Chongqing Medical University), Qingzhu Gao(MRC Laboratory of Molecular Biology), Di Qu(Xijing Hospital), Chao Hu(Central South University), Rui‐Xin Wu(Air Force Medical University), Shenglong Li(Dalian University of Technology)
Cited by 4
Related Papers
Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China
|The Lancet|2020|51.8k
RETRACTED: 6-month consequences of COVID-19 in patients discharged from hospital: a cohort study
|The Lancet|2021|4.3k
Antibody responses to SARS-CoV-2 in patients with COVID-19
|Nature Medicine|2020|3.1k
The JAK/STAT signaling pathway: from bench to clinic
|Signal Transduction and Targeted Therapy|2021|2.4k
Human Infection with a Novel Avian-Origin Influenza A (H7N9) Virus
|New England Journal of Medicine|2013|2.4k